Day One Biopharmaceuticals I (DAWN) Technical Analysis
$12.79▲2.65%
Market is closed - opens 8 PM, 23 Dec 2024
Insights
- Day One Biopharmaceuticals I is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Day One Biopharmaceuticals I stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Day One Biopharmaceuticals I stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Day One Biopharmaceuticals I stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 39.95 | Neutral |
Stochastic | 28.94, 16.77 | Neutral |
Ultimate Oscillator | 52.92 | Neutral |
Stochastic Relative Strength Index | 17.31, 6.47 | Buy |
Moving Average Convergence Divergence | -0.42, -0.38 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 12.85 | Sell |
20 | 13.26 | Sell |
50 | 14.08 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 12.86 | Sell |
20 | 13.2 | Sell |
50 | 13.73 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 12.81 | Neutral |
20 | 13.25 | Neutral |
50 | 14.21 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 12.52 | Sell |
20 | 12.64 | Sell |
50 | 13.19 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 12.52 | Buy |
20 | 12.45 | Sell |
50 | 12.92 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 12.97 |
Resistance L2 | 12.82 |
Resistance L1 | 12.64 |
Pivot Point | 12.49 |
Support L1 | 12.31 |
Support L2 | 12.16 |
Support L3 | 11.98 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.